Acumen Pharmaceuticals Capital Expenditures (CapEx) Growth & History (ABOS)
Acumen Pharmaceuticals's capital expenditures (capex) was $88,000 for fiscal 2025.
View full Acumen Pharmaceuticals company overviewAcumen Pharmaceuticals annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $88,000 | $72,000 | +450.00% |
| 2024 | 2024-12-31 | $16,000 | −$5,000 | −23.81% |
| 2023 | 2023-12-31 | $21,000 | −$140,000 | −86.96% |
| 2022 | 2022-12-31 | $161,000 | $121,000 | +302.50% |
| 2021 | 2021-12-31 | $40,000 | — | — |
Acumen Pharmaceuticals quarterly capital expenditures (capex)
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $0 | −$9,000 | — |
| Q1 2026 | 2026-03-31 | $0 | −$79,000 | — |
| Q4 2025 | 2025-12-31 | $0 | $0 | — |
| Q3 2025 | 2025-09-30 | $0 | $0 | — |
| Q2 2025 | 2025-06-30 | $9,000 | $4,000 | +80.00% |
| Q1 2025 | 2025-03-31 | $79,000 | $68,000 | +618.18% |
| Q4 2024 | 2024-12-31 | $0 | −$14,000 | — |
| Q3 2024 | 2024-09-30 | $0 | −$7,000 | — |
| Q2 2024 | 2024-06-30 | $5,000 | $5,000 | — |
| Q1 2024 | 2024-03-31 | $11,000 | $11,000 | — |
| Q4 2023 | 2023-12-31 | $14,000 | −$21,000 | −60.00% |
| Q3 2023 | 2023-09-30 | $7,000 | −$74,000 | −91.36% |
| Q2 2023 | 2023-06-30 | $0 | −$36,000 | — |
| Q1 2023 | 2023-03-31 | $0 | −$9,000 | — |
| Q4 2022 | 2022-12-31 | $35,000 | — | — |
| Q3 2022 | 2022-09-30 | $81,000 | $73,000 | +912.50% |
| Q2 2022 | 2022-06-30 | $36,000 | — | — |
| Q1 2022 | 2022-03-31 | $9,000 | — | — |
| Q3 2021 | 2021-09-30 | $8,000 | — | — |
Acumen Pharmaceuticals capital expenditures (capex) trends
Between the periods ended 2021-12-31 and 2025-12-31, Acumen Pharmaceuticals's capital expenditures (capex) increased from $40,000 to $88,000, a change of $48,000. The latest reported quarter, Q2 2026, shows $0.
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Acumen Pharmaceuticals source filings ↗